<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>Division of Vaccine and Infectious Disease, Fred Hutchinson Cancer Center&#xA;&#xA;TCRs, influenza virus, anti-tumor immunity, books, dogs, Venice</description><link>https://bsky.app/profile/pgtimmune.bsky.social</link><title>@pgtimmune.bsky.social - Paul Thomas</title><item><link>https://bsky.app/profile/pgtimmune.bsky.social/post/3mgqg3rrbmk22</link><description>Are you a fan of #fibroblasts? Do you think about the lung ECM in your quiet moments? Then join David Boyd &amp; a panel discussion as he presents  “Integrated Longitudinal Transcriptomic &amp; Proteomic Analysis of the Murine Lung Response to Influenza A Virus&#34; t.co/2IdbWJVNDQ&#xA;https://t.co/2IdbWJVNDQ</description><pubDate>10 Mar 2026 22:26 +0000</pubDate><guid isPermaLink="false">at://did:plc:kcdheikds6a2gnst5ify3yps/app.bsky.feed.post/3mgqg3rrbmk22</guid></item><item><link>https://bsky.app/profile/pgtimmune.bsky.social/post/3m6frtlwhvs2j</link><description>Two complementary studies from our group out today: a therapeutic peptide vaccine trial for fibrolamellar carcinoma (FLC) &amp; TIRTL-Seq, our robust method for deep quantitative paired TCR sequencing a🧵w/ @markyarchoan.bsky.social &amp; @pogorely.bsky.social https://www.nature.com/articles/s41592-025-02907-9</description><pubDate>24 Nov 2025 21:36 +0000</pubDate><guid isPermaLink="false">at://did:plc:kcdheikds6a2gnst5ify3yps/app.bsky.feed.post/3m6frtlwhvs2j</guid></item><item><link>https://bsky.app/profile/pgtimmune.bsky.social/post/3m52yl2gy4c25</link><description>After many rewarding years at @StJudeResearch surrounded by exceptional colleagues &amp; groundbreaking science, I’m delighted to join @fredhutch to push boundaries in viral &amp; cancer immunology. Grateful to St. Jude and looking forward to what’s next at FH! More here: https://www.fredhutch.org/en/news/center-news/2025/11/paul-thomas-viral-immunologist-vidd.html</description><pubDate>07 Nov 2025 21:12 +0000</pubDate><guid isPermaLink="false">at://did:plc:kcdheikds6a2gnst5ify3yps/app.bsky.feed.post/3m52yl2gy4c25</guid></item><item><link>https://bsky.app/profile/pgtimmune.bsky.social/post/3ltxlgntcns2m</link><description>How much of the TCR repertoire can we make sense of? Can your TCR and GEX data be put in the context of other conditions/tissues? How many varieties of T cells are in the repertoire zoo? All these questions (&amp; more) addressed in our latest preprint: MetaCoNGA https://www.biorxiv.org/content/10.1101/2025.05.31.657155v1 . a 🧵</description><pubDate>14 Jul 2025 23:52 +0000</pubDate><guid isPermaLink="false">at://did:plc:kcdheikds6a2gnst5ify3yps/app.bsky.feed.post/3ltxlgntcns2m</guid></item></channel></rss>